DiaMedica Announces Regulatory Clearance to Initiate Bridging Clinical Trial for DM199
MINNEAPOLIS, MINNESOTA–(Marketwired – Sept. 12, 2016) – DiaMedica Inc. (the “Company“) (TSX VENTURE:DMA)(OTCQB:DMCAF) DiaMedica announced that it has received [...]